Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 4651 to 4665 of 7691 results

  1. Intravaginal devices and pessaries combined with pelvic floor muscle training for managing pelvic floor dysfunction: How effective is a pessary or intravaginal device combined with pelvic floor muscle training for managing pelvic floor dysfunction, compared with pelvic floor muscle training alone?

    Recommendation ID NG210/22 Question Intravaginal devices and pessaries combined with pelvic floor muscle training for managing pelvic floor

    Research recommendation
    Published
    7 January 2022

  2. Assistive technology: How effective is assistive technology in enabling disabled children and young people with severe complex needs to express their views to education, health, and social care services?

    Recommendation ID NG213/01 Question Assistive technology: How effective is assistive technology in enabling disabled children and young

    Research recommendation
    Published
    8 April 2022

  3. Pelvic floor muscle training for preventing bowel symptoms associated with pelvic floor dysfunction: How effective is pelvic floor muscle training in preventing bowel symptoms associated with pelvic floor dysfunction?

    Recommendation ID NG210/10 Question Pelvic floor muscle training for preventing bowel symptoms associated with pelvic floor dysfunction:

    Research recommendation
    Published
    7 January 2022

  4. Pelvic floor muscle training for preventing pelvic floor dysfunction during pregnancy for women in higher-risk groups: How effective is pelvic floor muscle training in preventing pelvic floor dysfunction during pregnancy in women who are in higher-risk groups?

    Recommendation ID NG210/03 Question Pelvic floor muscle training for preventing pelvic floor dysfunction during pregnancy for women in

    Research recommendation
    Published
    7 January 2022

  5. Unsupervised physical activity to improve symptoms of pelvic floor dysfunction: How effective is unsupervised physical activity (such as walking or swimming) at improving symptoms associated with pelvic floor dysfunction?

    Recommendation ID NG210/14 Question Unsupervised physical activity to improve symptoms of pelvic floor dysfunction: How effective is unsupervised

    Research recommendation
    Published
    7 January 2022

  6. Virtual and in-person contact time for pelvic floor muscle training: How effective is virtual contact with a trainer, compared with in-person contact, for pelvic floor muscle training?

    Recommendation ID NG210/23 Question Virtual and in-person contact time for pelvic floor muscle training: How effective is virtual contact

    Research recommendation
    Published
    7 January 2022

  7. Weight training to improve symptoms of pelvic floor dysfunction: How effective is weight training at improving symptoms associated with pelvic floor dysfunction?

    Recommendation ID NG210/13 Question Weight training to improve symptoms of pelvic floor dysfunction: How effective is weight training at

    Research recommendation
    Published
    7 January 2022

  8. Surveillance strategies: How frequently should surveillance imaging be conducted, and which imaging modality should be used for people with stage IIB to IIIC melanoma?

    Recommendation ID NG14/05 Question Surveillance strategies: How frequently should surveillance imaging be conducted, and which imaging

    Research recommendation
    Published
    4 August 2022

  9. How should the symptomatic treatment of neuropathic pain relate to its cause?

    Recommendation ID CG173/7 Question How should the symptomatic treatment of neuropathic pain relate to its cause? Any explanatory

    Research recommendation
    Published
    26 October 2020

  10. How many children in the UK are infected with chronic hepatitis B and C and which subgroups of the population do they come from?

    Recommendation ID PH43/9 Question How many children in the UK are infected with chronic hepatitis B and C and which subgroups of the population

    Research recommendation
    Published
    9 June 2015

  11. How strong are the associations between hearing and visual loss, and sleep patterns and positive and negative health outcomes, in particular the development of dementia, disability and frailty? What are the most effective and cost-effective interventions to protect hearing and vision and improve sleep and what is their effect on the development of dementia, disability and frailty?

    Recommendation ID NG16/4 Question How strong are the associations between hearing and visual loss, and sleep patterns and positive and

    Research recommendation
    Published
    9 December 2015

  12. How many confirmatory diagnostic biopsies are carried out before definitive treatment, in people who have a clinical diagnosis of basal cell carcinoma and which different modalities used to treat basal cell carcinoma?

    Recommendation ID DG19/3 Question How many confirmatory diagnostic biopsies are carried out before definitive treatment, in people who

    Research recommendation
    Published
    12 January 2016

  13. How many people in the UK are infected with chronic hepatitis B and C and which subgroups of the population do they come from?

    Recommendation ID PH43/10 Question How many people in the UK are infected with chronic hepatitis B and C and which subgroups of the population

    Research recommendation
    Published
    9 June 2015

  14. HPV testing:- What is the comparative effectiveness of single-step laboratory diagnostic tests to identify human papillomavirus (HPV) against current diagnostic test algorithms and reference standards in people with cancer of the oropharynx?

    Recommendation ID NG36/2 Question HPV testing:- What is the comparative effectiveness of single-step laboratory diagnostic tests to identify

    Research recommendation
    Published
    6 April 2016

  15. Identification and monitoring:- What are the demographic characteristics and rates of progression to type 2 diabetes among people with a high risk score but normal blood glucose levels (fasting plasma glucose of less than 5.5 mmol/l or HbA1c of less than 42 mmol/mol)? How does this compare with people who have both a high risk score and blood glucose levels that indicate impaired glucose regulation (fasting plasma glucose 5.5–6.9 mmol/l or HbA1c 42–47 mmol/mol (6.0–6.4%)?

    Recommendation ID PH38/2 Question Identification and monitoring:- What are the demographic characteristics and rates of progression to

    Research recommendation
    Published
    9 June 2015